🔎 Trials Near Me

Home › Lymphedema

Pag-aaral pangklinika para sa Lymphedema na nagre-recruit sa U.S.

25 pag-aaral para sa Lymphedema ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.

Mga lungsod na may pinakamaraming pag-aaral

Ayos sa estado

Mga pag-aaral na kamakailan lamang in-update

Opisyal na teksto ng pag-aaral (English)

A Prospective Natural History Study of Lymphatic Anomalies

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
1 Day – 100 Years · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05731141

Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial.

Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06989099

A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management

Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT03248310

A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons

Nagre-recruitObservasyonal na pag-aaral
Edad 22 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06725030

Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]

Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06125743

LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy

Nagre-recruit
Edad 18 hanggang 75 · Kababaihan · Na-update Ago 12, 2026 · NCT05366699

Evaluate Advanced Pneumatic Compression Device With Revised Compression Programming for Lymphedema Treatment

Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT07613931

IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases

Nagre-recruitPhase 2
Edad 45 pataas · Kababaihan · Na-update Ago 10, 2026 · NCT06092892

Screening For BCRL In Targeted Therapy For Breast Cancer

Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 80 · Kababaihan · Na-update Hul 13, 2026 · NCT05142800

Lymphedema Surveillance Study

Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Kababaihan · Na-update May 7, 2026 · NCT02743858

ILR to Prevent BRCL_MCC 23608

Nagre-recruit
Edad 18 hanggang 75 · Kababaihan · Na-update Abr 30, 2026 · NCT07127003

Prospective Screening for Breast Cancer-related Lymphedema

Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Kababaihan · Na-update Dis 24, 2025 · NCT01521741

Vascular Lab Resource (VLR) Biorepository

Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 19, 2025 · NCT05628948

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

Nagre-recruitPhase 3
Edad 18 hanggang 75 · Kababaihan · Na-update Nob 10, 2025 · NCT06144164

Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks

Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2025 · NCT06574022

A Real-World Registry of Chronic Wounds and Ulcers

Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hul 16, 2025 · NCT02280733

Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema

Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 10, 2025 · NCT07012642

LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)

Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 11, 2025 · NCT04606030

Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)

Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 11, 2025 · NCT05695924

Pedal Pump and Leg Lymphedema

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 55 hanggang 100 · Lahat ng kasarian · Na-update Nob 18, 2024 · NCT06235463

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.